| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 02/17/2011 | US20110039759 Use of Secretin-Receptor Ligands in Treatment of Cystic Fibrosis (CF) and Chronic Obstructive Pulmonary Disease (COPD) |
| 02/17/2011 | US20110038949 Homeopathic formulation |
| 02/17/2011 | US20110038942 Beta-lactoglobulin-polysaccharide nanoparticles for hydrophobic bioactive compounds |
| 02/17/2011 | US20110038934 Pharmaceutical composition with atorvastatin active ingredient |
| 02/17/2011 | US20110038932 Methods and materials for treating conditions associated with metabolic disorders |
| 02/17/2011 | US20110038923 Adipocyte-specific constructs and methods for inhibiting platelet-type 12 lipoxygenase expression |
| 02/17/2011 | US20110038913 Polymeric endoprostheses with modified erosion rates and methods of manufacture |
| 02/17/2011 | US20110038906 Aloe powder, aloe juice, and method for producing the same |
| 02/17/2011 | US20110038903 Apparatus and Process for Generating and Harvesting Adult Stem Cells and Fluid Associated with it from Skin and Omentum for Medical, Cosmetic, and Veterinary Use |
| 02/17/2011 | US20110038859 Methods for the treatment of il-1beta related diseases |
| 02/17/2011 | US20110038841 Multi-Transgenic Pigs for Diabetes Treatment |
| 02/17/2011 | US20110038836 Device and Method for Transfecting Cells for Therapeutic Use |
| 02/17/2011 | US20110038835 Anilides and analogs as rho kinase inhibitors |
| 02/17/2011 | US20110038827 Elevation of the plasma hdl-cholesterol level |
| 02/17/2011 | US20110038799 Composition for treatment and improvement of diabetes comprising caveolin as active ingredient and a method for treatment of diabetes using it |
| 02/17/2011 | DE102009026357A1 Mixed oxide dispersion in water, where mixed oxide contains silicon, sodium, and either potassium, calcium, phosphorus and/or magnesium, useful to manufacture or prepare a food-, pharmaceutical- or cosmetic product |
| 02/17/2011 | CA2771299A1 Multi-transgenic pigs for diabetes treatment |
| 02/17/2011 | CA2771283A1 Nutritional compositions including exogenous nucleotides |
| 02/17/2011 | CA2771053A1 Floating microgranules |
| 02/17/2011 | CA2770793A1 Azetidinone compounds and medical use thereof |
| 02/17/2011 | CA2770724A1 Compounds and methods of use thereof |
| 02/17/2011 | CA2770688A1 Methods for preventing or treating metabolic syndrome |
| 02/17/2011 | CA2768877A1 Methods, compounds, and compositions for delivering 1,3-propanedisulfonic acid |
| 02/16/2011 | EP2284189A2 Nucleic acid molecules encoding fibroblast growth factor-like (FGF-like) polypeptides |
| 02/16/2011 | EP2284172A1 Immunomodulating heterocyclic compounds |
| 02/16/2011 | EP2284158A1 Quinoline compounds, pharmaceutical compositions, preparation methods and uses thereof |
| 02/16/2011 | EP2283869A2 Selected antibodies and duramycin peptides binding to anionic phospholipids and aminophospholipids and their use in the treatment of viral infections and cancer |
| 02/16/2011 | EP2283868A2 Selected antibodies and duramycin peptides binding to anionic phospholipids and aminophospholipids and their use in the treatment of viral infections and cancer |
| 02/16/2011 | EP2283865A1 Method of increasing testosterone and related steroid concentrations in women |
| 02/16/2011 | EP2283835A2 Method and preparation for treating metabolic stress |
| 02/16/2011 | EP2283834A2 Therapeutic compositions comprising ketone bodies or their precursors |
| 02/16/2011 | EP2283833A2 Amines and amides for the treatment of diseases |
| 02/16/2011 | EP2283819A1 DPP IV inhibitor formulations |
| 02/16/2011 | EP2283809A1 Microneedle array using porous substrate and process for producing same |
| 02/16/2011 | EP2283022A1 Furo ý3, 2-b¨pyrr0l-3-0nes as cathepsin s inhibitors |
| 02/16/2011 | EP2283019A1 Gpr119 receptor agonists |
| 02/16/2011 | EP2283008A2 Pyrrole derivatives, preparation of same and therapeutic application thereof |
| 02/16/2011 | EP2283007A2 Pyrrole derivatives, preparation of same and therapeutic application thereof |
| 02/16/2011 | EP2282997A2 4-methyl-4,5-dihydro-1h-pyrazole-3-carboxamide useful as cannabinoid cb1 neutral antagonist |
| 02/16/2011 | EP2282735A1 Compounds, compositions and methods for making the same |
| 02/16/2011 | EP1694356B1 Regulation of food preference using glp-1 agonists |
| 02/16/2011 | EP1577388B1 Adiponectin promoter and use thereof |
| 02/16/2011 | EP1424080B1 Gnrh agonist combination drugs |
| 02/16/2011 | CN1972926B Indole derivatives as histamine receptor antagonists |
| 02/16/2011 | CN1960727B Naphthalene derivatives useful as histamine-3-receptor ligands |
| 02/16/2011 | CN1846456B Communication system for wireless microphone |
| 02/16/2011 | CN101977910A N-azabicyclic carboxamide derivatives, preparation thereof and therapeutic use thereof |
| 02/16/2011 | CN101977615A Inhibitor for blood phosphorus level elevation |
| 02/16/2011 | CN101977596A New use for cannabinoids |
| 02/16/2011 | CN101977502A Fungicide hydroximoyl-tetrazole derivatives |
| 02/16/2011 | CN101975829A Screening method and application of alpha-glucosidase inhibitor |
| 02/16/2011 | CN101974391A Wine with functions of resisting thrombosis, lowering blood lipid and expelling toxins and production method thereof |
| 02/16/2011 | CN101974248A Method for separating tea pigment components |
| 02/16/2011 | CN101974090A GLP-1 analog fusion proteins |
| 02/16/2011 | CN101974077A Novel polypeptide compound |
| 02/16/2011 | CN101974071A Insulin B chain HLA-A*0201 restrictive CTL epitope modified peptide ligand and acquisition method and application thereof |
| 02/16/2011 | CN101974034A Method for synthesizing flavone alkyl phosphate compound and application thereof in cholesterol esterase inhibitor medicine |
| 02/16/2011 | CN101973998A Pyrrolopyrimidine A2b selective antagonist compounds, their synthesis and use |
| 02/16/2011 | CN101973922A Atorvastatin semi-strontium salt polymorphs as well as preparation and application thereof as HMG-CoA enzyme inhibitor |
| 02/16/2011 | CN101972449A Chinese medicinal material earthworm enzyme and peptide compound preparation and preparation method thereof |
| 02/16/2011 | CN101972439A Traditional Chinese medicine for treating diabetic foot |
| 02/16/2011 | CN101972438A Traditional Chinese medicine for treating diabetic acral necrosis |
| 02/16/2011 | CN101972434A Traditional Chinese medicine for treating diabetes mellitus |
| 02/16/2011 | CN101972425A Multifunctional jerusalem artichoke capsules for treating diabetes by nourishing pancreas, eliminating root causes and suppressing cancer |
| 02/16/2011 | CN101972422A Traditional Chinese medicine for treating diabetic pruritus |
| 02/16/2011 | CN101972416A Medicament for treating diabetes |
| 02/16/2011 | CN101972415A Traditional Chinese medicine-decocted soup or granule preparation for recuperating and treating diabetes |
| 02/16/2011 | CN101972410A Traditional Chinese medicine for treating diabetic constipation |
| 02/16/2011 | CN101972386A Traditional Chinese medicine for treating diabetic gout |
| 02/16/2011 | CN101972382A Thirst-quenching pulse-invigorating stasis-dissolving pill and preparation method thereof |
| 02/16/2011 | CN101972374A Traditional Chinese medicine for treating diabetic gastroplegia |
| 02/16/2011 | CN101972373A Chinese medicinal preparation for treating hypertension, hyperglycemia and hyperlipidemia |
| 02/16/2011 | CN101972372A Medicament for treating hyperlipidaemia and preparation method thereof |
| 02/16/2011 | CN101972367A Traditional Chinese medicine for treating diabetic peripheral neuropathy |
| 02/16/2011 | CN101972357A Blood lipid-lowering healthcare tea |
| 02/16/2011 | CN101972352A Traditional Chinese medicine for treating diabetic nephropathy |
| 02/16/2011 | CN101972343A Traditional Chinese medicine for treating diabetic oculopathy |
| 02/16/2011 | CN101972333A Medicament for eliminating turbid urines and activating blood stasis |
| 02/16/2011 | CN101972327A Traditional Chinese medicine for treating diabetic heart disease |
| 02/16/2011 | CN101972319A Medicinal composition for treating hypertension insulin resistance and preparation method thereof |
| 02/16/2011 | CN101972316A Traditional Chinese medicinal composition, traditional Chinese medicinal preparation, preparation methods and use thereof |
| 02/16/2011 | CN101972315A Traditional Chinese medicinal composition and preparation method and use thereof |
| 02/16/2011 | CN101972311A Method for purifying Tartary buckwheat flavone |
| 02/16/2011 | CN101972303A Traditional Chinese medicine for treating diabetic diarrhea |
| 02/16/2011 | CN101972301A Traditional Chinese medicine for treating diabetic coronary disease |
| 02/16/2011 | CN101972294A New usage of eucommia ulmoides chemical composition as vessel protective agent |
| 02/16/2011 | CN101972291A Helichrysum arenarium Moench extractive as well as preparation method and application thereof |
| 02/16/2011 | CN101972273A Application of medicine in preparing medicines for treating diabetes mellitus |
| 02/16/2011 | CN101972260A Rosuvastatin calcium oral drug composition |
| 02/16/2011 | CN101972257A Medicine composite containing moxifloxacin |
| 02/16/2011 | CN101972255A Rosiglitazone hydrochloride-containing pharmaceutical composition and preparation method thereof |
| 02/16/2011 | CN101972245A Composition capable of promoting insulin secretion and inhibiting generation of advanced glycosylation end products |
| 02/16/2011 | CN101797385B Oral calcium pharmaceutical composition |
| 02/16/2011 | CN101579477B Traditional Chinese medicine foot soaping liquid for treating diabetes |
| 02/16/2011 | CN101519392B Compound treating diabetes and relevant complicating diseases and preparation method and application thereof |
| 02/16/2011 | CN101508739B Radio frequency auxiliary method for extracting glossy ganoderma seed polysaccharide |
| 02/16/2011 | CN101450996B Glucose responding type polyphosphazene hydrogel |
| 02/16/2011 | CN101406619B Hypoglycemic capsules containing astragalus and leech, and preparation method thereof |
| 02/16/2011 | CN101406598B Chinese medicine composite for treating diabetes and preparation method thereof |
| 02/16/2011 | CN101396432B Method for concentrating and separating flavonoids from toona sinensis leaves |